[
  {
    "ts": "2025-11-05T05:37:53+00:00",
    "headline": "5 Revealing Analyst Questions From CVS Health’s Q3 Earnings Call",
    "summary": "CVS Health’s third quarter was shaped by strong top-line momentum across its core businesses, notably pharmacy and health insurance, with management attributing results to improved execution in retail pharmacy, market share gains, and early progress on Aetna’s operational turnaround. CEO David Joyner emphasized that CVS’s “diversified business and progress on becoming the most trusted health care company” helped offset reimbursement pressures and challenges in Health Care Delivery. The company’s",
    "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-cvs-053753469.html",
    "source": "StockStory",
    "provider": "yfinance",
    "raw": {
      "id": "10c6b885-902d-331d-a3ba-b21221876d58",
      "content": {
        "id": "10c6b885-902d-331d-a3ba-b21221876d58",
        "contentType": "STORY",
        "title": "5 Revealing Analyst Questions From CVS Health’s Q3 Earnings Call",
        "description": "",
        "summary": "CVS Health’s third quarter was shaped by strong top-line momentum across its core businesses, notably pharmacy and health insurance, with management attributing results to improved execution in retail pharmacy, market share gains, and early progress on Aetna’s operational turnaround. CEO David Joyner emphasized that CVS’s “diversified business and progress on becoming the most trusted health care company” helped offset reimbursement pressures and challenges in Health Care Delivery. The company’s",
        "pubDate": "2025-11-05T05:37:53Z",
        "displayTime": "2025-11-05T05:37:53Z",
        "isHosted": true,
        "bypassModal": false,
        "previewUrl": null,
        "thumbnail": {
          "originalUrl": "https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f",
          "originalWidth": 1400,
          "originalHeight": 700,
          "caption": "CVS Cover Image",
          "resolutions": [
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/TljU2TKBBw.om82sijmNHg--~B/aD03MDA7dz0xNDAwO2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f.cf.webp",
              "width": 1400,
              "height": 700,
              "tag": "original"
            },
            {
              "url": "https://s.yimg.com/uu/api/res/1.2/pwdlNJA5IleaBBwQa3TKTg--~B/Zmk9c3RyaW07aD0xMjg7dz0xNzA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/stockstory_922/eb6a18a2df4cd69d91dd2d643f0b356f.cf.webp",
              "width": 170,
              "height": 128,
              "tag": "170x128"
            }
          ]
        },
        "provider": {
          "displayName": "StockStory",
          "url": "https://stockstory.org/"
        },
        "canonicalUrl": {
          "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-cvs-053753469.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "clickThroughUrl": {
          "url": "https://finance.yahoo.com/news/5-revealing-analyst-questions-cvs-053753469.html",
          "site": "finance",
          "region": "US",
          "lang": "en-US"
        },
        "metadata": {
          "editorsPick": false
        },
        "finance": {
          "stockTickers": [
            {
              "symbol": "CVS"
            }
          ],
          "premiumFinance": {
            "isPremiumNews": false,
            "isPremiumFreeNews": false
          }
        },
        "storyline": null
      }
    }
  }
]